The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study
- 1 October 2006
- journal article
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 7 (5) , 318-324
Abstract
The use of antipsychotics is associated with an increased risk of obesity. This consideration makes it important to search for determinants that can predict the risk for antipsychotic-induced obesity. In this cross-sectional study, we investigated whether polymorphisms in the HTR2C gene were associated with obesity (body mass index >30 kg/m2) in patients using antipsychotics. We examined polymorphisms in the promoter region of the HTR2C gene ((HTR2C:c.1–142948(GT)n, rs3813928 (-997 G/A), rs3813929 (-759 C/T), rs518147 (-697 G/C)) and an intragenic polymorphism (rs1414334:C>G). The results of the logistic regression were expressed as adjusted odds ratios (OR). In total, we included 127 patients mainly diagnosed with schizophrenia or schizoaffective disorder (89%). The results indicate that a combined genotype carrying the variant HTR2C:c.1–142948(GT)n 13 repeat allele, the common allele rs3813929 C, the variant allele rs518147 C and the variant allele rs1414334 C is significantly related to an increased risk of obesity (OR 3.71 (95% confidence interval: 1.24–11.12)).Keywords
This publication has 24 references indexed in Scilit:
- The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatmentProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2005
- Reasons for Switching between Antipsychotics in Daily Clinical PracticePharmacopsychiatry, 2005
- Weight gain associated with the −759C/T polymorphism of the 5HT2C receptor and olanzapineAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2005
- Clozapine‐induced weight gain associated with the 5HT2C receptor −759C/T polymorphismAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2005
- A 5‐HT2C receptor promoter polymorphism (HTR2C − 759C/T) is associated with obesity in women, and with resistance to weight loss in heterozygotesAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2003
- Polymorphism of the Promoter Region of the Serotonin 5-HT2C Receptor Gene and Clozapine-Induced Weight GainAmerican Journal of Psychiatry, 2003
- −759C/T genetic variation of 5HT2C receptor and clozapine-induced weight gainThe Lancet, 2002
- Association of antipsychotic druginduced weight gain with a 5-HT2C receptor gene polymorphismThe Lancet, 2002
- Identification of polymorphic loci in the promoter region of the serotonin 5-HT 2C receptor gene and their association with obesity and Type II diabetesDiabetologia, 2000
- What's wrong with Bonferroni adjustmentsBMJ, 1998